Paccar Tumbles 1.12% as $270M Volume Ranks 412th in Market Activity Amid Insider Selling and Mixed Analyst Outlooks

Generated by AI AgentAinvest Volume Radar
Tuesday, Sep 2, 2025 6:52 pm ET1min read
Aime RobotAime Summary

- Paccar (PCAR) fell 1.12% with $270M volume, ranking 412th in market activity amid mixed institutional and insider trading.

- CFO/CEO sold $4.48M shares (91.44%+15.19% reduction), contrasting Magnetar/Ieq's 24.7%+6,654-share purchases.

- Q2 earnings beat estimates at $1.37/share but revenue dropped 15.7% to $6.96B, prompting analyst price target adjustments.

- Technical indicators conflicted (pivot top sell vs. 3-month MACD buy), while analysts remain divided with 14 "Hold" recommendations.

- Backtests project 8.11% 3-month rise between $104.56-$113.37, with key resistance at $100.46 and stop-loss at $95.58 (-3.32%).

On September 2, 2025,

(PCAR) fell 1.12% with a trading volume of $270 million, ranking 412th in market activity. Institutional investors showed mixed signals: Magnetar Financial LLC and Ieq Capital LLC increased stakes by 24.7% and 6,654 shares, respectively, while the CFO and CEO sold combined $4.48 million in shares, marking a 91.44% and 15.19% reduction in their holdings. The company reported Q2 earnings of $1.37 per share, exceeding estimates, but revenue dropped 15.7% year-over-year to $6.96 billion. Analysts adjusted price targets, with ISI lowering its target to $114 from $115, while others like Argus and upgraded or neutralized ratings. A Seeking Alpha analysis highlighted concerns over economic weakening, downgrading Paccar’s outlook.

Insider selling and revenue contraction weighed on sentiment, contrasting with institutional buying. The stock’s 52-week range of $84.65–$118.81 and a beta of 0.91 suggest moderate volatility. A dividend of $0.33 per share was announced, yielding 1.3% annually. Technical indicators showed conflicting signals: a short-term sell signal from a pivot top and a buy signal from the 3-month MACD. Volume surged on declining prices, signaling potential near-term caution. Analysts remain divided, with two “Strong Buy” ratings, four “Buy,” and eight “Hold” recommendations, averaging a $107.68 price target.

Backtest results indicate a 8.11% projected rise over three months, with a 90% probability of trading between $104.56 and $113.37. The stock faces resistance at $100.46 and support at $98.45. A break above $100.46 could trigger a buy signal, while a drop below $98.45 may prompt selling. The model recommends a stop-loss at $95.58 (-3.32%) to mitigate risk amid mixed fundamentals.

Comments



Add a public comment...
No comments

No comments yet